The latest update is out from RAPT Therapeutics ( (RAPT) ).
RAPT Therapeutics announced that William Rieflin has resigned from its Board of Directors, with Lori Lyons-Williams appointed as the new Chair. The Board has reduced its size to six directors and added Linda Kozick to the Audit Committee, indicating a strategic realignment in leadership and governance.
More about RAPT Therapeutics
YTD Price Performance: 2.45%
Average Trading Volume: 3,227,034
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $58.38M
See more insights into RAPT stock on TipRanks’ Stock Analysis page.